ArticleJournal of enzyme inhibition and medicinal chemistry2025
Statement of Retraction: Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.